Pershing Square Faces Analyst Downgrades and a 209% Borrow Cost Before Monday's Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
PS reports Q3 2026 results on Monday after a bruising month. The stock fell 17% in October before recovering 9% over the past week to close at $49.15, a rebound that still leaves it well below where it was trading when its own NAV per share stood at $76.93 in late September.
The borrow market captures the tension neatly. Borrowing PS shares costs 209% annually, one of the highest rates in the asset management sector. That figure has actually eased from a peak above 278% in late September, when availability hit its tightest point of the past year (virtually zero shares available to borrow). Today availability has loosened to around 27%, meaning roughly one share remains available for every three already lent out. That is still tight by most standards, and the ORTEX short score of 77.5 out of 100 reflects persistent negative positioning that has held broadly steady through October. Options positioning adds to the cautious read: the put/call ratio jumped to 2.03 on October 29, above its 20-day average of 1.72.
The analyst community turned sharply more negative in October. Bank of America downgraded PS to Underperform and cut its target from $54 to $38, the most significant move in the coverage group. Citigroup also downgraded to Sell, while Wells Fargo trimmed its Underweight target further. Against that, UBS raised its target to $44 while keeping a Neutral rating, and RBC nudged its target up to $44. The mean target across the coverage group now sits at around $44.67, below the current price of $49.15, an unusual configuration that signals the Street collectively sees the stock as overvalued at current levels. The core disagreement is structural. Those constructive on PS point to fee-paying AUM of $22.3 billion, an 82% to 84% FRE margin, and the permanent-capital structure that makes roughly 98% of the fee base redemption-resistant. The bear case rests on concentration risk in a 10 to 15 position portfolio, key-person dependence on William Ackman, and the fact that PSUS was trading at a 20% discount to NAV when the quarter closed, compressing any performance-fee optionality.
Ownership is dominated by insiders. Pershing Square Management, LLC holds 75% of the class as last disclosed in August, with Ackman personally at 45.3% via a Schedule 13G filing. None of the 13D/G filings indicate an activist posture. The most recent open-market transaction on record was Ackman's purchase of around 82,000 shares in late April at $22.61, a transaction that looks distant relative to today's price. ORTEX puts the probability of PS joining the Russell 1000 and Russell 3000 at 68% in the December 2026 semi-annual review, with potential buying flow of around $99 million from index trackers if the addition is confirmed. The announcement date is currently expected on November 13.
Monday's result will test whether the recovery in fee-paying AUM from Q2 can support the premium the stock still commands over the analyst consensus, and whether any tightening in the PSUS discount gives the bear case less traction.
Stocks in this article
See the live data behind this article on ORTEX.
Open PS on ORTEX →How this article was generated
- Generated
- 30 Oct 2026, 04:19
- Data as of
- 30 Oct 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesIndex Rebalance
- Validation notes
- soft: missing section mentions: short interest (informational only)
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.